Diligence memo · auto-generated · as of July 2, 2026
Biobot Analytics, Inc.
Biobot Analytics, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Biobot Analytics, Inc. operates in Software / Tech, based in CAMBRIDGE, MA, USA. Population health analytics powered by wastewater.
Sub-sector tags: Health Tech, Analytics.
Capital & rounds (filed)filed
Biobot Analytics, Inc. has raised $41M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $21M on 2021-07-23.
Most recent recorded round closed around 2025-05-23.
Valuation (modeled)modeled
Provath models Biobot Analytics, Inc. at approximately $74M (range $33M–$111M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.74× the median modeled value of Series B Software / Tech companies in 2025–2027 (95 peers) — value vs value, same stage and era. Within the normal band (74% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 21 months.
Last raise 13 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 1.2× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 89% of Software / Tech peers (3920 compared).
Modeled value ranks above 66% of those peers.
Closest niche peers: Machina Labs, Inc., Metaview Technologies Inc., Felix Technologies Inc., Foxglove Technologies Inc., NetBox Labs, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.